According to Cosmo Pharmaceuticals's latest financial reports the company's total liabilities are $0.32 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $0.31 B | -4.49% |
2021-12-31 | $0.33 B | 37.56% |
2020-12-31 | $0.24 B | 12.44% |
2019-12-31 | $0.21 B | 3.66% |
2018-12-31 | $0.20 B | 518.59% |
2017-12-31 | $33.44 M | 13.8% |
2016-12-31 | $29.38 M | -21.63% |
2015-12-31 | $37.49 M | -57.95% |
2014-12-31 | $89.18 M | 182.64% |
2013-12-31 | $31.55 M | -12.44% |
2012-12-31 | $36.03 M | 90.4% |
2011-12-31 | $18.92 M | -57.47% |
2010-12-31 | $44.5 M | 166.2% |
2009-12-31 | $16.71 M | -17.69% |
2008-12-31 | $20.31 M | 15.15% |
2007-12-31 | $17.63 M | -35.14% |
2006-12-31 | $27.19 M | -16.55% |
2005-12-31 | $32.59 M | -1.3% |
2004-12-31 | $33.02 M |